會員登入
註冊
財經中心
掌握大中華生技市場脈動．亞洲專業華文生技產業月刊
【Intro】Skinopathy
2021-07-12 / 財經中心
CompanyIntroductionSkinopathyIncisamedicaltechnologycompanycreatingArtificialIntelligence,AugmentedReality,andautomationtechnologythatwillofferthepublicandmedicalcommunitystate-of-the-artskindiseasemi...
【Intro】Single Cell Technology, Inc.
2021-07-12 / 財經中心
CompanyIntroductionSingleCellTechnology(SCT)wasestablishedin2008.WenamedourantibodydiscoverytechnologyaftertheGreekwordatheneum,meaninganinstituteforscientificlearning.AbTheneum™technologywasind...
【Intro】Taiwania Capital Management Corporation
2021-07-12 / 財經中心
CompanyIntroductionTaiwaniaCapitalisaventurecapitalfirmthatwasfoundedin2017bytheNationalDevelopmentFundoftheExecutiveYuanofTaiwanandprivateenterprises.Ourmissionistoestablishapartnershipwithcompaniesw...
【Intro】Bay Area Health Trust
2021-07-12 / 財經中心
CompanyIntroductionBayAreaHealthTrustisaHamilton,Ontario-basedcompanythatoperateslifesciencebusinessestoreturnvaluetoitsbeneficiaries,includingHamiltonHealthSciencesandMcMasterUniversity.Asauniqueorga...
【Intro】DCI Partners Co., Ltd.
2021-07-12 / 財經中心
CompanyIntroductionDCIPartnersisaJapan-basedlifescienceventurecapitalfirmfocusedoninvestmentsinthepharmaceutical, biotechnologyand medicaldeviceindustries.Briefdescriptionofmainproductsorservices Mana...
【Intro】LuminX Biotech Co., Ltd
2021-07-12 / 財經中心
CompanyIntroductionLuminXBiotechdedicatestoacceleratetheoptimizationofcell-therapy-productsthroughspecificunderstandingoftherapeuticcellsdistributionin-vivo,long-termviability,aswellastheirbiologicalf...
【Intro】cytena Bioprocess Solution co., Ltd - Cellink Group
2021-07-12 / 財經中心
CompanyIntroductioncytenaBioprocessSolutionco.,Ltd(cBS)isfoundedin2018andisasubsidiaryofalistedSweden3DprintingcompanyCellinkAB.cytenaBioprocessSolutionsfocusesonofferingbioprocesssolutionsfor,butnotl...
【Intro】C4U CORPORATION
2021-07-12 / 財經中心
CompanyIntroductionC4UCorporationisabiotechnologyventurecompanyfoundedinMay2018,byDr.TomojiMashimo(currentlyProfessorofUniversityofTokyo)etal.Wehavedevelopedproprietarygeneeditingtechniquessuchasoneus...
【Intro】Momotaro-Gene Inc.
2021-07-12 / 財經中心
CompanyIntroductionMomotaro-GeneInc.isacancergenetherapycompany.WeareusingREIC/Dkk-3geneisolatedatOkayamaUniversity.OurAdenovirusvectorcarryingREIC(Ad-REIC)showsagreatpromisetocurethesolidtumor.Briefd...
【Intro】Antaimmu BioMed Co., Ltd.
2021-07-12 / 財經中心
CompanyIntroduction主要開發新一代免疫治療生物藥劑Neobody™，透過對癌細胞的高度專一標靶作用、增強免疫檢查點阻斷功能、並避免對正常細胞的攻擊而減少副作用，達到提高整體免疫系統對癌細胞的偵測以及毒殺作用。安肽生醫目前已經開發了噬菌體展示平台(phagedisplayplatform)，表現人類合成抗體庫、原生性抗體庫、以及免疫小鼠的抗體庫，可用於篩選對癌症標靶分子...
【Intro】Steminent Biotherapeutics Inc.
2021-07-12 / 財經中心
CompanyIntroduction仲恩生醫專注於脂肪間葉幹細胞(Adipose-DerivedMesenchymalStemCells,AD-MSCs)藥物化技術平台之開發，發展針對不治及難治之症的幹細胞藥物。仲恩生醫具備獨特處裡技術，為亞洲第一個進入台、日、美臨床二期試驗階段的幹細胞生技新藥公司，並同時取得治療小腦萎縮症的美國及日本孤兒藥資格（日本由授權合作伙伴取得孤兒藥資格）。台灣小腦萎縮...
【Intro】Medigen Biotechnology Corporation
2021-07-12 / 財經中心
CompanyIntroduction基亞生物科技股份有限公司成立於1999年底，結合台灣生技醫療研發能量、國際臨床開發經驗、與最新的技術商化競爭力，鋪建了完整專利保護的各種專題，基亞將有效地將研發與技術轉化為全球各國法規單位認可的醫療產品。 本公司鎖定亞洲重大疾病「肝病」與「癌症」兩大領域的新產品為開發核心。透過過去多年的努力耕耘，基亞生技已逐漸發展成為全方位的生物醫藥集團，其事業已涵蓋了：新藥...
